Each filer's latest filing for 82686Q101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Invus Global Management, LLC
13G/A
|
7.0% |
8/13/2026
Event 6/30/2026
|
|
| Invus Public Equities, L.P. | 6.1% | ||
| Invus Public Equities Advisors, LLC | 6.1% | ||
| Invus Global Management, LLC | 6.1% | ||
| Siren, L.L.C. | 6.1% | ||
| Avicenna Life Sci Master Fund LP | 0.9% | ||
| Avicenna Life Sci Master GP LLC | 0.9% | ||
| Ulys, L.L.C. | 0.9% | ||
| Raymond Debbane | 7.0% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 16 | 504 k | $5.07M |
| 2026 Q2 | 72 | 23.6 M | $253M |
| 2026 Q1 | 56 | 19.9 M | $102M |
| 2025 Q4 | 58 | 18.3 M | $107M |
| 2025 Q3 | 54 | 19.7 M | $96.5M |
| 2025 Q2 | 56 | 19.8 M | $108M |
| 2025 Q1 | 60 | 21.9 M | $60.6M |
| 2024 Q4 | 66 | 24.8 M | $168M |
| 2024 Q3 | 70 | 28.2 M | $487M |
| 2024 Q2 | 72 | 29.2 M | $540M |
| 2024 Q1 | 65 | 28.2 M | $599M |
| 2023 Q4 | 35 | 20.6 M | $345M |
| 2023 Q3 | 29 | 19.7 M | $188M |
| 2023 Q2 | 30 | 19.2 M | $102M |
| 2023 Q1 | 30 | 18.4 M | $110M |
| 2022 Q4 | 28 | 18.6 M | $276M |
| 2022 Q3 | 30 | 19.3 M | $190M |
| 2022 Q2 | 26 | 11.0 M | $124M |
| 2022 Q1 | 27 | 12.8 M | $231M |
| 2021 Q4 | 23 | 10.3 M | $247M |
| 2021 Q3 | 8 | 1.96 M | $39.4M |
| 2021 Q2 | 7 | 2.26 M | $56.4M |
| 2021 Q1 | 7 | 2.55 M | $55.9M |
| 2020 Q4 | 4 | 542 k | $10.2M |
| 2020 Q3 | 3 | 542 k | $8.14M |